SPECTRILA Trademark

Trademark Overview

On Friday, March 1, 2019, a trademark application was filed for SPECTRILA with the United States Patent and Trademark Office. The USPTO has given the SPECTRILA trademark a serial number of 88321747. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 28, 2022. This trademark is owned by medac Gesellschaft für klinische Spezialpräparate mbH. The SPECTRILA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating cancer and hematological diseases
spectrila

General Information

Serial Number88321747
Word MarkSPECTRILA
Filing DateFriday, March 1, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 28, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating cancer and hematological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Namemedac Gesellschaft für klinische Spezialpräparate mbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWedel 22880
DE
Party Namemedac Gesellschaft für klinische Spezialpräparate mbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWedel 22880
DE

Trademark Events

Event DateEvent Description
Monday, November 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, April 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 31, 2022SOU EXTENSION 5 GRANTED
Friday, March 25, 2022SOU EXTENSION 5 FILED
Thursday, March 31, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 25, 2022TEAS EXTENSION RECEIVED
Wednesday, March 9, 2022ASSIGNED TO EXAMINER
Wednesday, September 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 30, 2021SOU EXTENSION 4 GRANTED
Monday, August 30, 2021SOU EXTENSION 4 FILED
Monday, August 30, 2021TEAS EXTENSION RECEIVED
Wednesday, March 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 22, 2021SOU EXTENSION 3 GRANTED
Monday, March 22, 2021SOU EXTENSION 3 FILED
Monday, March 22, 2021TEAS EXTENSION RECEIVED
Saturday, August 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 27, 2020SOU EXTENSION 2 GRANTED
Thursday, August 27, 2020SOU EXTENSION 2 FILED
Thursday, August 27, 2020TEAS EXTENSION RECEIVED
Wednesday, March 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 16, 2020SOU EXTENSION 1 GRANTED
Monday, March 16, 2020SOU EXTENSION 1 FILED
Monday, March 16, 2020TEAS EXTENSION RECEIVED
Tuesday, October 22, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 27, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 7, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 24, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 24, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 22, 2019ASSIGNED TO LIE
Wednesday, July 17, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 10, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 10, 2019NON-FINAL ACTION E-MAILED
Friday, May 10, 2019NON-FINAL ACTION WRITTEN
Friday, May 10, 2019ASSIGNED TO EXAMINER
Wednesday, March 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 5, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

spectrila hematological diseases cancer treating preparations pharmaceutical